Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Boehringer Ingelheim
Cerilliant
Citi
Mallinckrodt
Baxter
Dow
Cipla
Colorcon

Generated: May 26, 2018

DrugPatentWatch Database Preview

TESLASCAN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Teslascan patents expire, and when can generic versions of Teslascan launch?

Teslascan is a drug marketed by Ic Targets and is included in one NDA.

The generic ingredient in TESLASCAN is mangafodipir trisodium. Additional details are available on the mangafodipir trisodium profile page.
Summary for TESLASCAN
US Patents:0
Applicants:1
NDAs:1
Clinical Trials: 1
DailyMed Link:TESLASCAN at DailyMed
Drug patent expirations by year for TESLASCAN

US Patents and Regulatory Information for TESLASCAN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for TESLASCAN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 ➤ Sign Up ➤ Sign Up
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 ➤ Sign Up ➤ Sign Up
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 ➤ Sign Up ➤ Sign Up
Ic Targets TESLASCAN mangafodipir trisodium INJECTABLE;INJECTION 020652-001 Nov 26, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Accenture
Federal Trade Commission
Mallinckrodt
US Department of Justice
AstraZeneca
US Army
Merck
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.